Literature DB >> 11706107

Prevalence of cognitive impairment: data from the Indianapolis Study of Health and Aging.

F W Unverzagt1, S Gao, O Baiyewu, A O Ogunniyi, O Gureje, A Perkins, C L Emsley, J Dickens, R Evans, B Musick, K S Hall, S L Hui, H C Hendrie.   

Abstract

BACKGROUND: The epidemiology and natural history of cognitive impairment that is not dementia is important to the understanding of normal aging and dementia.
OBJECTIVE: To determine the prevalence and outcome of cognitive impairment that is not dementia in an elderly African American population.
METHOD: A two-phase, longitudinal study of aging and dementia. A total of 2212 community-dwelling African American residents of Indianapolis, IN, aged 65 and older were screened, and a subset (n = 351) received full clinical assessment and diagnosis. Subsets of the clinically assessed were seen again for clinical assessment and rediagnosis at 18 and 48 months. Weighted logistic regression was used to generate age-specific prevalence estimates.
RESULTS: The overall rate of cognitive impairment among community-dwelling elderly was 23.4%. Age-specific rates indicate increasing prevalence with increasing age: 19.2% for ages 65 to 74 years, 27.6% for ages 75 to 84 years, and 38.0% for ages 85+ years. The most frequent cause of cognitive impairment was medically unexplained memory loss with a community prevalence of 12.5%, followed by medical illness-associated cognitive impairment (4.0% prevalence), stroke (3.6% prevalence), and alcohol abuse (1.5% prevalence). At 18-month follow-up, 26% (17/66) of the subjects had become demented.
CONCLUSIONS: Cognitive impairment short of dementia affects nearly one in four community-dwelling elders and is a major risk factor for later development of dementia.

Entities:  

Mesh:

Year:  2001        PMID: 11706107     DOI: 10.1212/wnl.57.9.1655

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  81 in total

1.  Reproduction beyond menopause: how old is too old for assisted reproductive technology?

Authors:  David Banh; Dara L Havemann; John Y Phelps
Journal:  J Assist Reprod Genet       Date:  2010-05-08       Impact factor: 3.412

2.  Incidence and risk factors for cognitive impairment no dementia and mild cognitive impairment in African Americans.

Authors:  Frederick W Unverzagt; Adesola Ogunniyi; Vanessa Taler; Sujuan Gao; Kathleen A Lane; Olusegun Baiyewu; Oye Gureje; Valerie Smith-Gamble; Ann Hake; Hugh C Hendrie; Kathleen S Hall
Journal:  Alzheimer Dis Assoc Disord       Date:  2011 Jan-Mar       Impact factor: 2.703

3.  Preventing cognitive decline in older African Americans with mild cognitive impairment: design and methods of a randomized clinical trial.

Authors:  Barry W Rovner; Robin J Casten; Mark T Hegel; Benjamin E Leiby
Journal:  Contemp Clin Trials       Date:  2012-03-02       Impact factor: 2.226

Review 4.  Aging-related changes in neuroimmune-endocrine function: implications for hippocampal-dependent cognition.

Authors:  Ruth M Barrientos; Matthew G Frank; Linda R Watkins; Steven F Maier
Journal:  Horm Behav       Date:  2012-02-18       Impact factor: 3.587

5.  Nutrient biomarker patterns, cognitive function, and MRI measures of brain aging.

Authors:  G L Bowman; L C Silbert; D Howieson; H H Dodge; M G Traber; B Frei; J A Kaye; J Shannon; J F Quinn
Journal:  Neurology       Date:  2011-12-28       Impact factor: 9.910

6.  Prevalence and incidence rates of dementia and cognitive impairment no dementia in the Mexican population: data from the Mexican Health and Aging Study.

Authors:  Silvia Mejia-Arango; Luis Miguel Gutierrez
Journal:  J Aging Health       Date:  2011-10

7.  Identification of mild cognitive impairment in ACTIVE: algorithmic classification and stability.

Authors:  Sarah E Cook; Michael Marsiske; Kelsey R Thomas; Frederick W Unverzagt; Virginia G Wadley; Jessica B S Langbaum; Michael Crowe
Journal:  J Int Neuropsychol Soc       Date:  2012-10-25       Impact factor: 2.892

8.  Neuropsychological characteristics of mild cognitive impairment subgroups.

Authors:  O L Lopez; J T Becker; W J Jagust; A Fitzpatrick; M C Carlson; S T DeKosky; J Breitner; C G Lyketsos; B Jones; C Kawas; L H Kuller
Journal:  J Neurol Neurosurg Psychiatry       Date:  2005-08-15       Impact factor: 10.154

Review 9.  Classification and epidemiology of MCI.

Authors:  Rosebud Roberts; David S Knopman
Journal:  Clin Geriatr Med       Date:  2013-11       Impact factor: 3.076

Review 10.  Mild cognitive impairment: ten years later.

Authors:  Ronald C Petersen; Rosebud O Roberts; David S Knopman; Bradley F Boeve; Yonas E Geda; Robert J Ivnik; Glenn E Smith; Clifford R Jack
Journal:  Arch Neurol       Date:  2009-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.